Holen Sie sich die Stockscreener-App
0.4641
22.65%
-0.1359
Handel nachbörslich:
.47
0.0059
+1.27%
Schlusskurs vom Vortag:
$0.60
Offen:
$0.52
24-Stunden-Volumen:
2.01M
Relative Volume:
9.28
Marktkapitalisierung:
$49.94M
Einnahmen:
$1.29M
Nettoeinkommen (Verlust:
$-29.87M
KGV:
-1.2892
EPS:
-0.36
Netto-Cashflow:
$-14.70M
1W Leistung:
-28.38%
1M Leistung:
-25.25%
6M Leistung:
-4.11%
1J Leistung:
-33.70%
1-Tages-Spanne:
$0.46
$0.52
1-Wochen-Bereich:
$0.46
$0.67
52-Wochen-Spanne:
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Firmenname
VolitionRX Ltd
Sektor
Branche
Telefon
646 650 1351
Adresse
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Vergleichen Sie VNRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.4641 | 64.56M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-02-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-02-17 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-16 | Eingeleitet | Maxim Group | Buy |
| 2018-05-14 | Bestätigt | The Benchmark Company | Buy |
| 2016-09-07 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-02-01 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
VolitionRx prices $6 million public offering of common stock and warrants By Investing.com - Investing.com South Africa
VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus
VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq
VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants - Yahoo Finance
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga
VolitionRx (VNRX) Plans Public Offering to Bolster Development a - GuruFocus
VolitionRx announces proposed public offering of common stock By Investing.com - Investing.com Australia
Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com South Africa
Volitionrx stock tumbles on proposed public offering - Investing.com India
VolitionRx announces offering of common stock and warrants, no amount given - TipRanks
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants - Stock Titan
Live market analysis of VolitionRx LimitedJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
VolitionRx Limited Stock Analysis and ForecastPrice Momentum Alerts & Build Diversified Portfolios With Ease - earlytimes.in
Is VolitionRx Limited a candidate for recovery playFed Meeting & Reliable Price Action Trade Plans - newser.com
Will a bounce in VolitionRx Limited offer an exit2025 Macro Impact & Real-Time Volume Analysis - newser.com
Is VolitionRX Limited stock resilient in recession scenariosJuly 2025 Setups & Weekly High Return Forecasts - newser.com
Will VolitionRX Limited stock boost dividends furtherNew Guidance & Accurate Buy Signal Notifications - newser.com
Beyond the Genome: Volition Showcases Revolutionary Nu.Q Platform for Epigenetic Drug Discovery - Stock Titan
VolitionRX (NYSEAMERICAN:VNRX) Trading 9% HigherShould You Buy? - MarketBeat
H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 By Investing.com - Investing.com Australia
VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh - GuruFocus
Why analysts remain bullish on VolitionRx Limited stockQuarterly Trade Report & Safe Entry Zone Tips - newser.com
VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services for Drug Developers - citybuzz
VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ - GuruFocus
What indicators show strength in VolitionRx Limited2025 Volume Leaders & Verified Entry Point Signals - newser.com
Can VolitionRX Limited stock sustain free cash flowLayoff News & Stock Timing and Entry Methods - newser.com
$200M Market Opportunity: Volition Teams with $4B Healthcare Giant Hologic for Epigenetic Testing Service - Stock Titan
Silicon Valley - FinancialContent
What drives VolitionRx Limited stock priceEx-Dividend Date Alerts & Free Popular Stock Picks Selection - earlytimes.in
Institutional scanner results for VolitionRx LimitedGlobal Markets & Accurate Trade Setup Notifications - newser.com
News impact scoring models applied to VolitionRx LimitedJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
Understanding VolitionRx Limited’s price movementWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com
Using Python tools to backtest VolitionRx Limited strategiesMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Real time pattern detection on VolitionRx Limited stock2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
VolitionRX Limited (NYSEAMERICAN:VNRX) Sees Large Growth in Short Interest - MarketBeat
How to monitor VolitionRx Limited with trend dashboardsIndex Update & Precise Buy Zone Tips - newser.com
How to use a screener to detect VolitionRx Limited breakoutsJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Signal strength of VolitionRx Limited stock in tech scannersMarket Growth Summary & Stock Portfolio Risk Control - newser.com
Bear Alert: What is the long term forecast for VolitionRx Limited stockMarket Rally & Long-Term Growth Plans - khodrobank.com
Will VolitionRx Limited bounce back from current supportJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Aug Breakouts: Whats the MACD signal for VolitionRx Limited2025 Short Interest & Technical Confirmation Alerts - خودرو بانک
C O R R E C T I O N -- The FUTR Corporation/17.09.25News - Ariva
Market Moves: How volatile is VolitionRx Limited stockJuly 2025 PostEarnings & High Win Rate Trade Tips - خودرو بانک
Update Report: Can The PNC Financial Services Group Inc stock double in the next yearMarket Growth Report & Fast Moving Market Watchlists - خودرو بانک
Gains Recap: Is VolitionRx Limited affected by consumer sentimentTrade Risk Report & High Accuracy Investment Signals - خودرو بانک
Finanzdaten der VolitionRX Ltd-Aktie (VNRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
VolitionRX Ltd-Aktie (VNRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Innes Guy Archibald | Director |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
966,814 |
| Reynolds Cameron John | President and CEO |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
2,609,847 |
| Reynolds Cameron John | President and CEO |
Jun 12 '25 |
Buy |
0.59 |
12,500 |
7,372 |
2,331,722 |
| Innes Guy Archibald | Director |
Jun 03 '25 |
Buy |
0.54 |
20,000 |
10,772 |
888,689 |
| Micallef Jacob Vincent | Chief Scientific Officer |
May 19 '25 |
Buy |
0.43 |
50,000 |
21,500 |
426,033 |
| Reynolds Cameron John | President and CEO |
May 19 '25 |
Buy |
0.44 |
20,000 |
8,730 |
2,319,222 |
| Reynolds Cameron John | President and CEO |
Mar 26 '25 |
Buy |
0.55 |
181,818 |
100,000 |
2,299,222 |
| Innes Guy Archibald | Director |
Mar 26 '25 |
Buy |
0.55 |
181,818 |
100,000 |
868,689 |
| Innes Guy Archibald | Director |
Dec 09 '24 |
Buy |
0.57 |
174,764 |
100,000 |
617,085 |
| STILL TIMOTHY I | Director |
Dec 09 '24 |
Buy |
0.57 |
87,382 |
50,000 |
1,487,382 |
0.17%
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):